Ex vivo expansion of CD34+ cells from bone marrow (BM) of AML in first remission is improved by exposure to high concentrations of stem cell factor and Flt3-ligand.

Herman, P.; Ferrant, Augustin; VanBockstaele, DR; Michaux, JL.; De Bruyère, Marc; Straetmans, Nicole

Ex vivo expansion of CD34+ cells from bone marrow (BM) of AML in first remission is improved by exposure to high concentrations of stem cell factor and Flt3-ligand.

Herman, P.

;

Ferrant, Augustin

;

VanBockstaele, DR

;

Michaux, JL.

;

Straetmans, Nicole

;et.al.

(1997)

Files

No attached file found for this publication.

Details

Authors

Herman, P.
Author
Ferrant, AugustinUCLouvain
Author
VanBockstaele, DR
Author
Michaux, JL.
Author
De Bruyère, MarcUCLouvain
Author
Straetmans, NicoleUCLouvain
Author

Affiliations

UCLouvainCliniques universitaires Saint-Luc
UCLouvainMD/MINT - Département de médecine interne

Citations

APA
Chicago
FWB

Herman, P., Ferrant, A., VanBockstaele, D., Michaux, JL., De Bruyère, M., & Straetmans, N. (1997). Ex vivo expansion of CD34+ cells from bone marrow (BM) of AML in first remission is improved by exposure to high concentrations of stem cell factor and Flt3-ligand. Blood, 90(10), 4286. (Original work published 1997)